Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest

This study demonstrates elevated FGF-23 serum levels to be potentially helpful in prediction of mortality and poor neurological outcome as early as 24 h post cardiac arrest.